Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-12-28 00:00:00 ET · period of report 2023-12-27 · accession 0001048477-23-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-28 | 2023-12-27 | BMRN | Enyedy Mark J | Dir | A - Grant | $0.00 | +2,180 | 2,180 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-27 | A | A | 2,180 | $0.00 | 2,180 | D | — | — | (F1) Restricted stock units granted on December 27, 2023. Price not applicable. |